Gabriel N. Hortobagyi, MD, FACP, Member
BCRF Executive Board of Scientific Advisors
Gabriel Hortobagyi chairs the Department of Breast Medical Oncology and directs the Breast Cancer Research Program at The University of Texas M.D. Anderson Cancer Center, where he holds the Nellie B. Connally Chair in Breast Cancer. He is Immediate Past President of the American Society of Clinical Oncology (ASCO) and is one of the world's leading authorities on the use of chemotherapy for breast cancer.
Dr. Hortobagyi is recipient of the 1997 Brinker International Award, the 1999 Vermeille Medal of the City of Paris, France, and was named Chevalier of l’Ordre de la Légion d’Honneur de France in 2001. Dr. Hortobagyi received the Glen Robbins Award in Breast Cancer Research from the New York Cancer Society and the Metropolitan Breast Cancer Group in April 2003, the Bristol-Myers Squibb 2003 Horizon Scientific Award; in 2004 Dr. Hortobagyi was the Jeffrey A. Gottlieb Memorial Award recipient, and was honored as the first recipient of the Umberto Veronesi Award for the Future Fight Against Breast Cancer. Dr. Hortobagyi has over 400 full-length publications in peer-reviewed journals; more than 300 invited papers; and over 100 book chapters to his credit.
His professional society activities include membership in the American Society of Clinical Oncology, where he has served on various task forces, chaired committees, served on the Board of Directors, and in 2005 was elected President for the term 2006-2007. He chairs the Data and Safety Monitoring Committee of the National Surgical Adjuvant Breast and Bowel Project; and served as President of the International Society of Senology. He served as a member of the U.S. National Committee for the International Union Against Cancer, and the National Cancer Institute’s Breast Cancer Progress Review Group. Dr. Hortobagyi is on the Medical Advisory Board of The Breast Cancer Research Foundation, chairs the Steering Committee of the Breast Health Global Initiative and the Health Advisory Board of the Susan G. Komen Breast Cancer Foundation, and was a member of the Integration Panel of the Breast Cancer Research Program of the Department of Defense.
|
